Paper36939199
Molecular principles of tissue invasion and metastasis.
Sulekha Suresh D and 1 other. Am J Physiol Cell Physiol, 2023. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Molecular principles of tissue invasion and metastasis. Papers, record 36939199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36939199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Integrins | |
| Neoplasm Metastasis | |
| Epithelial-Mesenchymal Transition | |
| Tumor Microenvironment |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42104475 | Prognostic value of PRAME gene promoter methylation and expression in hepatocellular carcinoma. | Clin Epigenetics | 2026 | https://conductscience.org/library/papers/42104475 | PubMed |
| 42098516 | Mechanistic insights into polyphenolic constituents from traditional Chinese medicines in inhibiting colorectal cancer metastasis. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42098516 | PubMed |
| 41574717 | Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/41574717 | PubMed |
| 41311372 | Emerging hallmarks and the rise of complexities and heterogeneity of tumor. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/41311372 | PubMed |
| 40592948 | Loss of adhesion impairs invasiveness and cell survival, contributing to the antimetastatic effect of cysteine proteases from Vasconcella cundinamarcensis in melanoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40592948 | PubMed |
| 40309242 | Effects of anesthetics on development of gynecological cancer. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40309242 | PubMed |
| 40303340 | Exosomes: innovative biomarkers leading the charge in non-invasive cancer diagnostics. | Theranostics | 2025 | https://conductscience.org/library/papers/40303340 | PubMed |
| 40148397 | An in- vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines. | Sci Rep | 2025 | https://conductscience.org/library/papers/40148397 | PubMed |
| 40094402 | Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1. | Mol Cancer Res | 2025 | https://conductscience.org/library/papers/40094402 | PubMed |
| 40057846 | Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/40057846 | PubMed |
| 39498383 | Phosphorylation of RelA/p65 Ser536 inhibits the progression and metastasis of hepatocellular carcinoma by mediating cytoplasmic retention of NF-κB p65. | Gastroenterol Rep (Oxf) | 2024 | https://conductscience.org/library/papers/39498383 | PubMed |
| 39469649 | Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche. | Front Oncol | 2024 | https://conductscience.org/library/papers/39469649 | PubMed |
| 39450562 | Melatonin and vitamin D as potential synergistic adjuvants for cancer therapy (Review). | Int J Oncol | 2024 | https://conductscience.org/library/papers/39450562 | PubMed |
| 38900236 | Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway. | Sci China Life Sci | 2024 | https://conductscience.org/library/papers/38900236 | PubMed |
| 38473317 | Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473317 | PubMed |
| 37936460 | Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/37936460 | PubMed |
| 37767111 | Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | https://conductscience.org/library/papers/37767111 | PubMed |
| 37594487 | Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/37594487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36939199
GET https://conductscience.org/api/papers/v1/36939199/authors